Role of Diffusion MRI in Differentiation of Various Bone Marrow Lesions
Role of MRI Diffusion in Differentiation Between Various Vertebral Bone Marrow Pathological Lesions. .
1 other identifier
observational
70
0 countries
N/A
Brief Summary
Bone marrow lesions are common, and imaging findings are associated with various aetiologies, as compared to conventional radiography and computed tomography (CT), MRI is a better non-invasive imaging modality to evaluate vertebral bone marrow, due to better soft-tissue contrast, so the aim of our study is the use of MRI diffusion in differentiating various vertebral bone marrow pathological lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 21, 2024
CompletedFirst Posted
Study publicly available on registry
November 25, 2024
CompletedStudy Start
First participant enrolled
December 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedNovember 29, 2024
November 1, 2024
12 months
November 21, 2024
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the efficacy of MRI diffusion in differentiation between Various Vertebral bone marrow pathological lesions. .
Primary (main): Establishing correlations between DWI findings and laboratory, clinical or histopathological results.
Baseline
Eligibility Criteria
\- All adult patients with various vertebral bone marrow lesions.
You may qualify if:
- All adult patients with vertebral lesions Clinically suspected or diagnosed by other modalities as X-ray or CT were included in the study.
You may not qualify if:
- Patients with metallic prosthesis which are not MRI compatible .
- patients with previous Vertebral surgery.
- patients with Vertebral Congenital anomalies
- Patients refused the examination.
- Patients who suffer from claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (5)
Leake RL, Mills MK, Hanrahan CJ. Spinal Marrow Imaging: Clues to Disease. Radiol Clin North Am. 2019 Mar;57(2):359-375. doi: 10.1016/j.rcl.2018.09.008. Epub 2018 Nov 17.
PMID: 30709475BACKGROUNDLin S, Ouyang T, Kanekar S. Imaging of Bone Marrow. Hematol Oncol Clin North Am. 2016 Aug;30(4):945-71. doi: 10.1016/j.hoc.2016.03.012.
PMID: 27444005BACKGROUNDDietrich O, Geith T, Reiser MF, Baur-Melnyk A. Diffusion imaging of the vertebral bone marrow. NMR Biomed. 2017 Mar;30(3). doi: 10.1002/nbm.3333. Epub 2015 Jun 26.
PMID: 26114411BACKGROUNDKarampinos DC, Ruschke S, Dieckmeyer M, Diefenbach M, Franz D, Gersing AS, Krug R, Baum T. Quantitative MRI and spectroscopy of bone marrow. J Magn Reson Imaging. 2018 Feb;47(2):332-353. doi: 10.1002/jmri.25769. Epub 2017 Jun 1.
PMID: 28570033BACKGROUNDPadhani AR, Koh DM. Diffusion MR imaging for monitoring of treatment response. Magn Reson Imaging Clin N Am. 2011 Feb;19(1):181-209. doi: 10.1016/j.mric.2010.10.004.
PMID: 21129641BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Eman A. Ahmed
Professor
- STUDY DIRECTOR
Shimaa F. Gad
Assistant professor
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 21, 2024
First Posted
November 25, 2024
Study Start
December 15, 2024
Primary Completion
December 1, 2025
Study Completion
January 1, 2026
Last Updated
November 29, 2024
Record last verified: 2024-11